The science behind the pills that manage pain
-
Upload
gani-kurniawan -
Category
Health & Medicine
-
view
203 -
download
1
description
Transcript of The science behind the pills that manage pain
The science behind the pills that manage pain
We all feel pain differently, depending on the severity of the injury or ache, as well as our health and our pain threshold. When you are in pain, nerve endings transmit the pain signal to the brain via the spinal cord. The brain then interprets the level of pain. There are two key types of painkillers that are commonly used. The first include ibuprofen and paracetamol, which block the body’s ‘prostaglandins’ (chemicals that produce swelling and pain) at the source of the pain, reducing swelling in the area and reducing the intensity of pain. These ‘aspirin medicines’ are used frequently for mild to moderate pain, but they can only work up to a certain intensity of pain. There are different types of painkillers within this group, such as anti-inflammatory medicines, like ibuprofen, which are commonly used to treat arthritis, sprains and strains. Aspirin is used to help lower the risk of blood clots when used in a low dosage, as they thin the blood. Paracetamol is what’s known as an analgesic, which is used for reducing pain and lowering a temperature. The second type of painkillers include morphine and codeine (narcotic medicines), which block the pain messages in the spinal cord and the brain. This is for much more severe pain. As both types of painkillers use slightly different methods to treat pain, they can be combined, such as in co-codamol, which blends codeine and paracetamol.
Pain Medications: Dosage and Indications MEDICATION STANDARD DOSAGE COMMENTS
Abbreviations: CrCl = creatinine clearance; GI = gastrointestinal; HIV-SN = HIV sensory neuropathy; LBP = low back pain; OA = osteoarthritis; PN = peripheral neuropathy; TCAs = tricyclic antidepressants
Acetaminophen 1 g Q6H PRN or 650 mg Q4H PRN Maximum dosage: 4 g per 24 hours or 2 g per 24 hours in patients with comorbid liver disease
First-line analgesia in noninflammatory
mild OA, LBP, mild PN because of
safety profile
Possible adverse effects: hepatotoxicity
(especially if taken with alcohol),
nephrotoxicity (with chronic overdose):
monitor liver and renal function when
using maximal dosages
Use caution and consider reducing total
dosage for patients with comorbid liver
disease or excessive alcohol intake
NSAIDs Ibuprofen
600-800 mg TID PRN for pain
Take with food
Schedule around the clock for
inflammatory condition (eg,
inflammatory OA) or persistent
symptoms
Can titrate up as tolerated and
based on risks to 800 mg TID
Maximum dosage: 3,200 mg/day in
divided doses or 1,800 mg/day for
patients at increased risk of adverse
effects Alternative NSAIDs Naproxen: 250-500 mg BID Sulindac: 150-200 mg BID Celecoxib: 200 mg QD Meloxicam: 7.5 mg QD For chronic pain, use for 2 weeks at initial dosage and reevaluate efficacy; titrate up as needed and if safe; if not effective after a 4-week trial, consider changing NSAID, or adding or changing to another intervention
For persistent noninflammatory and
inflammatory OA, LBP, mild PN
Possible adverse effects: GI bleeding,
abdominal pain, rash and
hypersensitivity, renal and hepatic
impairment, platelet aggregation
abnormalities
Avoid use in patients with peptic ulcer
disease or cirrhosis
Avoid ibuprofen in patients with history
of aspirin-induced asthma
Increased bleeding risk with concurrent
warfarin; if used, monitor closely
Increased risk of renal impairment in
patients on diuretics and those with
baseline renal dysfunction, congestive
heart failure, or cirrhosis
To minimize risks, use the lowest
effective dosage and try to use for short
periods of time
COX-2 inhibitors, such as celecoxib,
have higher risk of cardiovascular events
MEDICATION STANDARD DOSAGE COMMENTS
but fewer GI side effects than
nonselective COX inhibitors
Indomethacin is associated with
increased joint destruction; avoid using
for OA or LBP
Antidepressants: TCAs and others
Amitriptyline Start at 10-25 mg QHS; titrate upward every 3 days by 25 mg to achieve symptom relief, if tolerated; maximum daily dosage is 150 mg (use lower dosages for older patients) Nortriptyline Start at 10-25 mg QHS; titrate upward every 3 days by 25 mg to achieve symptom relief, if tolerated; maximum daily dosage is 150 mg (use lower dosages for older patients)
Consider for patients with comorbid
depression
Consider for neuropathic pain; also as
an adjunct in any type of LBP
unresponsive to acetaminophen and
NSAIDs
Small studies of PN have shown limited
or negative results with antidepressants
Drug interactions: RTV and other PIs
may increase the level of TCAs; start at
low dosage, increase slowly
Monitor serum TCA levels to avoid
cardiotoxicity at higher dosage levels
Possible TCA adverse effects:
anticholinergic (dry mouth, dizziness,
constipation, urinary retention, blurred
vision, orthostatic hypotension),
extrapyramidal symptoms,
incoordination; risk of cardiac conduction
abnormalities and overdose at higher
dosages
For neuropathic pain, other potential
agents include venlafaxine and
duloxetine; these are inadequately
studied in people with HIV infection or
show limited efficacy
Anticonvulsants Gabapentin: start at 300 mg QHS;
may increase every few days, as
tolerated, to achieve symptom relief;
first increase to BID, then TID, then
Consider for PN
Gabapentin: considered first-line for HIV-
SN (SeePeripheral Neuropathy)
Common adverse effects include
nausea, constipation, fatigue,
MEDICATION STANDARD DOSAGE COMMENTS
increase by 300 mg per dose to
maximum of 1,200 mg TID
Pregabalin: start at 25-50 mg TID;
may increase by 25-50 mg per dose
every few days as tolerated to
achieve symptom relief; maximum
dosage: 200 mg TID
Lamotrigine: start at 25 mg every
other day; titrate slowly to 200 mg
BID over the course of 6-8 weeks
somnolence, dizziness, truncal ataxia,
weight gain
To discontinue, taper over course of ≥7
days
Pregabalin: sometimes better tolerated
than gabapentin
Uncertain efficacy in HIV-related PN
Possible adverse effects include
somnolence, constipation, dizziness,
ataxia, and weight gain
To discontinue, taper over course of ≥7
days
Lamotrigine: has shown the greatest
efficacy in clinical trials for HIV-SN
Possible adverse effects: rash (including
Stevens-Johnson syndrome),
cytopenias, dizziness
To discontinue, taper slowly
Drug interactions: LPV/r may decrease
lamotrigine levels; may need to increase
lamotrigine dosage for therapeutic effect
Muscle relaxants (nonbenzo- diazepines)
Cyclobenzaprine (Flexeril) 5-10 mg TID; start with 5 mg doses for elderly patients and those with hepatic impairment; maximum dosage is 30 mg per 24 hours Baclofen 5-10 mg TID or QID; start with 5 mg doses for elderly patients and those with renal impairment; maximum dosage is 80 mg QD in divided doses
May be useful as adjunctive therapy for
acute back pain but not recommended
for chronic or subacute back pain
Common adverse effects include
drowsiness, dry mouth, and dizziness
Severe adverse effects include
arrhythmias, altered mental status, and
seizures
Opiate analgesics Options include: Tramadol (not a typical opiate; exact mechanism of action is unknown; acts in part as a central opioid agonist) Start with 50 mg QAM PRN pain, titrate upward by 50 mg/day every 3 days to 50 mg Q6H Maximum dosage: 400 mg/day, or 300 mg/day if >70 years of age; to
Use opioids for patients who have
severe pain refractory to other
interventions (pharmacologic or
nonpharmacologic) or who cannot
receive those interventions
MEDICATION STANDARD DOSAGE COMMENTS
discontinue, taper dosage in the same way In renal insufficiency with CrCl <30, reduce dose frequency to Q12H, and maximum dosage to 200 mg/day Weak opioids
Codeine
15-30 mg every 4-6 hours; titrate up
by 15 mg every 2-3 days to achieve
pain relief, if tolerated
Maximum dose: 60 mg; take with
food
Hydrocodone + acetaminophen
5 mg/500 mg fixed-dose tablet, 1-2
tablets Q6H PRN pain
Maximum dosage: 12 tablets per 24
hours; 6 tablets for elderly patients
and those with liver disease
Oxycodone + acetaminophen
5 mg/325 mg fixed-dose tablet (other
dosages available), 1-2 tablets Q6H
PRN pain
Maximum dosage: 12 tablets per 24
hours; 6 tablets for elderly patients
and those with liver disease Strong opioids
Morphine (immediate release)
10-30 mg every 3-4 hours PRN pain
Morphine (sustained release)
15-30 mg Q12H as scheduled
Start with weak opioids, assess safety,
efficacy, and usage; titrate up and move
to stronger opioids as needed
Use the lowest effective dosage
Use opioids cautiously in elderly patients
If needed for acute flares, try to limit use
to a designated short period of time
If needed for chronic pain, try to use a
sustained-release opioid (eg, sustained-
release morphine) around the clock, plus
shorteracting opioids (eg, hydrocodone)
for breakthrough pain as needed
Opioid therapy for chronic pain should
use a fixed-dose schedule, not PRN
dosing
Methadone may have utility for
neuropathic pain owing to its action on
NMDA receptors; start at low dosage
and titrate slowly because of its long
half-life; consult with pharmacist
Risk of dependence, overdose
(accidental or deliberate); monitor
closely
Adverse effects include oversedation,
hypotension and respiratory depression,
central nervous system stimulation or
somnolence, dizziness, constipation,
nausea, pruritus
Codeine and morphine can cause
urticarial reactions (hives)
For patients with renal and hepatic
impairment, use low dosages and
monitor carefully
When prescribing opioids, remember to
also give treatment for constipation
(docusate and senna)
MEDICATION STANDARD DOSAGE COMMENTS
doses; if pain control is inadequate,
consider dosing Q8H; may titrate up
by 15-30 mg PRN pain
Oxycodone (immediate release)
5-30 mg Q4H PRN pain
Oxycodone (sustained release)
10 mg Q12H as scheduled doses;
titrate up by 10-20 mg PRN; monitor
carefully
Methadone
Consult with pharmacist
Hydromorphone 2-4 mg Q4H PRN
Fentanyl transdermal
12-100 mcg patch Q72H; a small
proportion of patients will need
dosing Q48H to maintain a stable
blood level
Appropriate only for patients already
on stable dosage of other opiates;
start at equianalgesic (or lower)
dosage; consult with pharmacist;
use for chronic severe pain
Note that tramadol 37.5 mg +
acetaminophen 325 mg has shown pain
relief equivalent to codeine 30 mg +
acetaminophen 325 mg but with fewer
adverse effects (major adverse effect:
headache)
Chronic opioid therapy should
incorporate an opioid use agreement
that includes functional goals for
outcome, not reduction of pain intensity
alone